Differential survival with adjuvant immunotherapy in stage <scp>III</scp> acral versus non‐acral melanoma
The data that support the findings of this study are available from National Cancer Database (NCDB). Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the author(s) with the permission of National Cancer Database (NCDB).
Authors
- Clark C. Otley (ORCID: https://orcid.org/0000-0001-9712-8956)
- Deepti Behl (ORCID: https://orcid.org/0000-0002-8247-5055)
- Svetomir N. Markovic (ORCID: https://orcid.org/0000-0002-9238-4325)
- Giang Huong Nguyen (ORCID: https://orcid.org/0009-0002-9440-4243)
- Ruifeng Ray Guo
- Raslina Shrestha
- Duc Van Le
- Hue Thi Thu Tran (ORCID: https://orcid.org/0009-0000-8199-5676)
- Thuy Minh Tran
Institutions
- Mayo Clinic (US)
- Jacksonville College (US)
- Vinmec Times City International Hospital (VN)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2026-06-30
- DOI
- https://doi.org/10.1111/jdv.70567
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00